Clinical Trial Update: Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating quetiapine for delirium prophylaxis in high-risk critically ill patients has completed. The study was sponsored by the University of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Psychomotor Agitation | Phase 4 | Status: COMPLETED